Jim Walter will take on the role of vice-president of operations for Catalent’s Oral and Specialty Delivery business.
Catalent announced on Feb. 12, 2020 that it is appointing Jim Walter as vice-president of operations for its Oral and Specialty Delivery business. Walter will be responsible for Catalent’s Research Triangle Park, NC, Woodstock, IL, and Malvern, PA sites in the United States and its Swindon and Dartford sites in the United Kingdom.
Before his new role, Walter spent 23 years with Mallinckrodt Pharmaceuticals in various operational roles and was most recently the senior vice-president of operations and engineering at Tinuum Group, a US-based energy company.
“I am delighted to welcome Jim to head up the operations for this important part of the Catalent business,” said Jonathan Arnold, president of Catalent’s Oral and Specialty Delivery business unit, in a company press release. “The experience that he brings will ensure that the company continues to grow while providing our customers with the most efficient and operationally superior services.”
Source: Catalent
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.